Bitcoin fell about 2% since early October, trading near $82,393 on Oct. 19, following $228.4 million in redemptions from U.S. spot Bitcoin ETFs last week. These ETFs allow investors to gain Bitcoin exposure through brokerage shares, but the redemptions don't clarify the reasons behind withdrawals or price changes. Historically, October has been positive for Bitcoin in 10 of the last 13 years, earning the nickname 'Uptober,' though past trends don't guarantee future results. The Federal Reserve's upcoming policy meeting on Oct. 27-28 may influence market direction.
Bitcoin's recent price movement and ETF redemptions provide context for cryptocurrency market activity. For readers following this space, here is Pluang's market snapshot as of Oct 20, 2026 06:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 42 rose and 7 fell today. Notable movers include SAND at Rp1.067 with a 2.90% increase, BCH at Rp5.026.924 up 2.84%, and GRT at Rp429 rising 2.74%.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
